glp 1 agonist eli lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Eli Lilly's oral GLP-1 pill

Tirzepatide users were less likely to experience any major cardiovascular problems following surgery than people not on the drug (roughly 30% lower risk), though the rate of some problems like heart attacks remained roughly the same between the two groups

"Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract." Current Pharmaceutical Design , 24(18), 1990-2001

If you're feeling under the weather, your performance will likely suffer, making maintaining a strong immune system crucial

and entrepreneur and investor, John Shulman, ZOA is taking the category to new heights

GHK-Cu (Gly-His-Lys-Cu2+)

The resulting colorful liquids were transferred into the wells of a 24-well plate, with 500 L in each well